From USFDA
Lupin announced that its subsidiary, Gavis Pharmaceuticals LLC, has received final approval for its Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5mg/300mg, 7.5mg/300mg and 10mg/300mg from United States Food and Drug Administration to market a generic equivalent of MilKart Inc's Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5mg/300mg, 7.5mg/300mg and 10mg/300mg.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
